Overview
Jingyan Cao practices practicing medicine in Harbin, China.
Their clinical expertise encompasses Mesothelioma, Lung Cancer, Heart Tumor, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingyan Y. Cao
Is Jingyan Y. Cao a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Jingyan Y. Cao is classified as an Experienced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingyan Y. Cao participate in research or clinical trials?
Yes. Jingyan Y. Cao has published 24 articles and abstracts on conditions like Mesothelioma. You can view a list of Jingyan Y. Cao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Heart TumorCao isExperienced. Learn about Heart Tumor.
- Lung AdenocarcinomaCao isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerCao isExperienced. Learn about Lung Cancer.
- MesotheliomaCao isExperienced. Learn about Mesothelioma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)